We are live on ! Find out more
SRRA

Sierra Oncology, Inc. Common Stock

Delisted

SRRA was delisted on the 30th of June, 2022.

Name Holding Trade Value Shares
Change
Change in
Stake
FM
1
Frazier Management
Washington
$13.9M
NLVP
2
New Leaf Venture Partners
New York
$8.59M
BC
3
Broadfin Capital
New York
$8.26M -$81K -1,262 -1%
MP
4
Mangrove Partners
Connecticut
$6.31M
PA
5
Perceptive Advisors
New York
$4.56M
PM
6
Prosight Management
Texas
$4.2M -$154K -2,407 -4%
VC
7
Vivo Capital
California
$4.17M
6CM
8
683 Capital Management
New York
$3.96M +$224K +3,488 +6%
BBA
9
Baker Bros. Advisors
New York
$3.42M
Renaissance Technologies
10
Renaissance Technologies
New York
$3.24M +$139K +2,163 +5%
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$2.92M
AC
12
Armistice Capital
New York
$2.67M -$64.2K -1,000 -3%
A
13
Abingworth
United Kingdom
$2.31M -$127K -1,985 -5%
Citadel Advisors
14
Citadel Advisors
Florida
$2.29M -$792K -12,333 -27%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$1.69M -$38K -592 -2%
Morgan Stanley
16
Morgan Stanley
New York
$1.46M -$101K -1,576 -7%
CS
17
Candriam SCA
Luxembourg
$1.23M
BCM
18
Bridgeway Capital Management
Texas
$903K +$366K +5,703 +76%
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$831K +$127K +1,984 +19%
SIM
20
Spark Investment Management
New York
$678K -$28.6K -445 -4%
O
21
OrbiMed
New York
$542K -$160K -2,500 -24%
HP
22
Hikari Power
Japan
$428K
GT
23
Greenleaf Trust
Michigan
$370K
SAM
24
Sectoral Asset Management
Quebec, Canada
$240K -$98.4K -1,533 -30%
PC
25
PA Capital
Virginia
$236K -$1.09K -17 -0.5%